Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DEBATE Study "DEvelopment of Endotype-based Biomarkers for the Monitoring of Greek pATiEnts With CRSwNP"

NCT07663409 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07663409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07663409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DEBATE Study "DEvelopment of Endotype-based Biomarkers for the Monitoring of Greek pATiEnts With CRSwNP"
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
June 29, 2026
Completion date
December 31, 2029
Enrollment
230 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

crswnp or crssnp patients